Ecopipam Tablets to Study Tourette Syndrome in Children and Adolescents - Open Label Extension

PHASE2CompletedINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

October 4, 2019

Primary Completion Date

November 11, 2022

Study Completion Date

November 11, 2022

Conditions
Tourette Syndrome in ChildrenTourette Syndrome in Adolescence
Interventions
DRUG

Ecopipam

Ecopipam HCl 12.5-, 37.5-. 50-, 75- and 100-mg tablets; 2 mg/kg/day target dose; oral administration daily in evenings.

Trial Locations (65)

10003

New York Neurology Associates P.C, New York

10019

Hapworth Research Inc., New York

10036

Mood Disorders Consulting Medicine PLLC, New York

14618

Finger Lakes Clinical Research, Rochester

19063

Suburban Research Associates, Media

29414

Coastal Pediatric Research, Charleston

30318

Rare Disease Research, LLC, Atlanta

31406

Meridian Clinical Research, Savannah

32561

Northwest Florida Clinical Research Group, LLC, Gulf Breeze

32607

Sarkis Clinical Trials, Gainesville

32789

Pediatric Neurology, PA, Winter Park

32803

APG Research LLC, Orlando

33013

Research in Miami Inc., Hialeah

33136

University of Miami, Miami

33180

MedBio Trials, North Miami

36303

Harmonex Neuroscience Research, Dothan

44106

University Hospitals Cleveland Medical Center, Cleveland

44130

North Star Medical Research LLC, Middleburg Heights

48105

Michigan Clinical Research Institute PC, Ann Arbor

49418

Helen DeVos Children's Hospital / Spectrum Health Medical Group, Wyoming

63304

St. Charles Psychiatric Associates dba Midwest Research Group, Saint Charles

66211

Psychiatric Associates, Overland Park

68526

Alivation Research, LLC, Lincoln

75243

Relaro Medical Trials, Dallas

76104

North Texas Clinical Trials, Fort Worth

77030

Baylor College of Medicine, Houston

77401

Houston Clinical Trials LLC, Bellaire

84663

Noetic Psychiatry, Springville

85016

Phoenix Children's Hospital, Phoenix

86021

CHU Poitiers, Poitiers

89128

Center for Psychiatry and Behavioral Medicine Inc., Las Vegas

90095

UCLA, Los Angeles

92108

PCSD-Feighner Research, San Diego

92705

Syrentis Clinical Research, Santa Ana

92805

Advanced Research Center Inc., Anaheim

06519

Yale School of Medicine, New Haven

33701-4825

University of South Florida, St. Petersburg

33609-4181

Pediatric Epilepsy and Neurology Specialists, Tampa

60612-3841

Rush University Medical Center, Chicago

60637-1447

The University of Chicago Hospitals, Chicago

60563-6510

AMR - Baber Research Inc., Naperville

02114

Massachusetts General Hospital, Boston

48302-1952

Neurobehavioral Medicine Group, Bloomfield Hills

63110-1093

Movement Disorders Center, St Louis

07856

The NeuroCognitive Institute, Mount Arlington

08043-1910

Clinical Research Center of NJ, Voorhees Township

10029-6504

Mount Sinai School of Medicine, New York

44012-1004

Quest Therapeutics of Avon Lake, Avon Lake

45229-3026

Cincinnati Childrens Hospital Medical Center, Cincinnati

37203-6502

Access Clinical Trials, Inc., Nashville

37232-0028

Vanderbilt University Medical Center, Nashville

78249-3539

Road Runner Research Ltd., San Antonio

22908-0829

University of Virginia, Charlottesville

98201-4077

Eastside Therapeutic Resource Inc dba Core Clinical Research, Everett

L1Z 0M1

The Kids Clinic Inc, Ajax

K2G 1W2

Center for Pediatric Excellence, Ottawa

H3T 1C5

CHU Sainte-Justine, Montreal

09648

Pharmakologisches Studienzentrum Chemnitz GmbH, Mittweida

80-542

Gdanskie Centrum Zdrowia Sp z o.o., Gdansk

80-546

Centrum Bada Klinicznych PI-House Sp. z o.o., Gdansk

80-952

Uniwersyteckie Centrum Kliniczne, Gdansk

40-123

NZOZ Wielospecjalistyczna Poradnia Lekarska Synapsis, Katowice

30-363

Centrum Medyczne Plejady, Krakow

31-503

Wojewdzki Specjalistyczny Szpital Dziecicy im. sw. Ludwika w Krakowie, Krakow

60-693

Med-Polonia Sp. z o. o., Poznan

Sponsors
All Listed Sponsors
lead

Emalex Biosciences Inc.

INDUSTRY